NeoPharm CO. LTD Strategic Asset Allocation Index
NeoPharm CO. LTD strategic asset allocation index. NeoPharm CO. LTD (092730) has a Strategic Asset Allocation Index of 16.7% as of March 2025. Strategic assets (PP&E of ₩29.24 Billion plus long-term investments of ₩-) total ₩29.24 Billion, measured against net assets of ₩174.63 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is NeoPharm CO. LTD's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of NeoPharm CO. LTD (2012–2022)
Strategic asset allocation index of NeoPharm CO. LTD from 2012 to 2022. This chart shows how NeoPharm CO. LTD's Strategic Asset Allocation Index has evolved across 9 annual periods from 2012 to 2022. As of March 2025, the index stands at 16.7%, representing strategic assets of ₩29.24 Billion against net assets of ₩174.63 Billion KRW. Check 092730 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
NeoPharm CO. LTD Strategic Asset Allocation Index by Year (2012–2022)
NeoPharm CO. LTD strategic asset allocation index by year from 2012 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for NeoPharm CO. LTD from 2012 to 2022, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 092730 market cap overview.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 6.6% | ₩9.34 Billion | ₩9.34 Billion | ₩- | ₩142.21 Billion | ▼ -0.9 pp |
| 2021 | 7.5% | ₩9.74 Billion | ₩9.74 Billion | ₩- | ₩130.30 Billion | ▼ -1.1 pp |
| 2020 | 8.6% | ₩10.12 Billion | ₩10.12 Billion | ₩- | ₩117.72 Billion | ▼ -2.9 pp |
| 2019 | 11.5% | ₩12.15 Billion | ₩10.50 Billion | ₩1.65 Billion | ₩105.69 Billion | ▼ -8.9 pp |
| 2018 | 20.4% | ₩12.10 Billion | ₩10.44 Billion | ₩1.66 Billion | ₩59.29 Billion | ▼ -1.7 pp |
| 2017 | 22.1% | ₩10.51 Billion | ₩8.92 Billion | ₩1.59 Billion | ₩47.58 Billion | ▼ -5.4 pp |
| 2016 | 27.5% | ₩10.62 Billion | ₩8.64 Billion | ₩1.98 Billion | ₩38.57 Billion | ▼ -18.2 pp |
| 2015 | 45.7% | ₩14.91 Billion | ₩8.26 Billion | ₩6.65 Billion | ₩32.62 Billion | ▲ +8.5 pp |
| 2012 | 37.2% | ₩11.12 Billion | ₩9.53 Billion | ₩1.59 Billion | ₩29.92 Billion | — |